Trending...
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 136
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
- UK Financial Ltd Confirms CATEX Exchange Integration of SMPRA and LTNS 1 Ahead of Compliance-Based Trading Activation
Abzena Holdings (US) LLC, a life sciences contract development and manufacturing organization (CDMO), will locate a significant biopharmaceutical manufacturing site in Lee County, creating 325 jobs and investing $213 million in Sanford, Governor Roy Cooper announced today.
"Abzena recognized North Carolina as a leader in biotechnology and knew this was the right place to develop and manufacture new medicines and grow their business," said Governor Cooper.
Abzena, with headquarters in San Diego, California and sites in Bristol, Pennsylvania and Cambridge, United Kingdom offers its customers solutions in integrated early discovery to mid-phase pharmaceutical production. Working with companies and academic groups from around the world, including many of the top biopharmaceutical brands, Abzena supports the development and manufacture of better treatments for patients. The company's project in Lee County will establish a state-of-the-art manufacturing facility featuring a design optimized for phase 3 and commercial manufacturing of biologics. Using a phased construction approach, the company will initially build four modular production suites, with each of those suites capable of housing two large bioreactors.
"We are very appreciative for the entire team representing North Carolina for their partnership and the office of U.S. Senator Thom Tillis during the decision process" said Jonathan Goldman MD, CEO of Abzena. "We are delighted to support our customers and the patients they serve with this investment in North Carolina. This builds on the successful launch of our second cGMP biologics facility in San Diego in 2020. We are pleased to provide high quality integrated drug development services covering research as well as the clinical and commercial phases without the need for technology transfer.
More on ncarol.com
"Innovative companies set a high bar for excellence, and with today's decision, North Carolina once again meets and exceeds those standards," said North Carolina Commerce Secretary Machelle Baker Sanders. "We welcome Abzena to the state's growing life science industry cluster. As a former executive in this industry myself, it's great to see how North Carolina is leading the way in the product lifecycle for new medicines that will improve and save lives."
Although specific wages will vary depending on job role, the aggregate average salary of the new positions will reach $63,308, bringing $19.1 million of positive payroll impact into the regional economy each year. The current average wage in Lee County stands at $42,516.
Abzena's project in North Carolina, which will be formally carried out by a new, wholly owned subsidiary company, will be facilitated by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by $1.5 billion. Using a formula that takes into account the new tax revenues generated by the new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $6,940,800, spread over 12 years. Over those 12 years, new state tax revenues generated by the new jobs will exceed $45 million.
State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
Abzena's JDIG agreement could also move as much as $771,200 into a fund that helps rural communities across the state attract business in the future. When companies select a site located in a Tier 2 county such as Lee, their JDIG agreements move some of the new tax revenue into the state's Industrial Development Fund – Utility Account. Local communities in more economically challenged areas of the state use grants from the Utility Account to build public infrastructure projects, which can improve a community's ability to attract companies to their regions.
"We welcome these new biomanufacturing jobs to Lee County," said N.C. Representative John Sauls. "Our region is a vital part of North Carolina's growing life science industry cluster, and we're excited to see the many opportunities that Abzena will bring to our community."
"Many economic development partners worked together to bring this investment to Lee County," said N.C. Senator Jim Burgin. "These community partners will continue to collaborate with Abzena to help the company succeed now and for many years to come."
Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of N.C. on this project were the North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, the Office of Senator Thom Tillis, Duke Energy, the City of Sanford, Lee County, and the Sanford Area Growth Alliance.
"Abzena recognized North Carolina as a leader in biotechnology and knew this was the right place to develop and manufacture new medicines and grow their business," said Governor Cooper.
Abzena, with headquarters in San Diego, California and sites in Bristol, Pennsylvania and Cambridge, United Kingdom offers its customers solutions in integrated early discovery to mid-phase pharmaceutical production. Working with companies and academic groups from around the world, including many of the top biopharmaceutical brands, Abzena supports the development and manufacture of better treatments for patients. The company's project in Lee County will establish a state-of-the-art manufacturing facility featuring a design optimized for phase 3 and commercial manufacturing of biologics. Using a phased construction approach, the company will initially build four modular production suites, with each of those suites capable of housing two large bioreactors.
"We are very appreciative for the entire team representing North Carolina for their partnership and the office of U.S. Senator Thom Tillis during the decision process" said Jonathan Goldman MD, CEO of Abzena. "We are delighted to support our customers and the patients they serve with this investment in North Carolina. This builds on the successful launch of our second cGMP biologics facility in San Diego in 2020. We are pleased to provide high quality integrated drug development services covering research as well as the clinical and commercial phases without the need for technology transfer.
More on ncarol.com
- SnapTax Launches AI-Powered Tax Planning Platform for Freelancers and 1099 Workers — Now Free for 90 Days
- MAG Magna Corp Targets Trillion-Dollar Opportunity by Tokenizing Rare Earth Assets Critical to AI, EVs, & Defense: MAG Magna Corp.: Stock Symbol: MGNC
- Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability
- Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
- VDG Virtuoso Continues Building Momentum for Independent Artists in the 910
"Innovative companies set a high bar for excellence, and with today's decision, North Carolina once again meets and exceeds those standards," said North Carolina Commerce Secretary Machelle Baker Sanders. "We welcome Abzena to the state's growing life science industry cluster. As a former executive in this industry myself, it's great to see how North Carolina is leading the way in the product lifecycle for new medicines that will improve and save lives."
Although specific wages will vary depending on job role, the aggregate average salary of the new positions will reach $63,308, bringing $19.1 million of positive payroll impact into the regional economy each year. The current average wage in Lee County stands at $42,516.
Abzena's project in North Carolina, which will be formally carried out by a new, wholly owned subsidiary company, will be facilitated by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by $1.5 billion. Using a formula that takes into account the new tax revenues generated by the new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $6,940,800, spread over 12 years. Over those 12 years, new state tax revenues generated by the new jobs will exceed $45 million.
State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
- NAIDOC Week Australia 2026 | 50 Years Deadly - Celebrates Culture, Resilience, and Global Connection
- Preeclampsia and Hurricane Survivor Gives Birth at the Same Hospital Where Her Father Passed Away
- PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain
- Rhealize Strategic Talent Advisory Co-Founder Dona Baker to Speak at DisruptHR YEG 15.0 in Edmonton on Hiring Innovation
- Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought
Abzena's JDIG agreement could also move as much as $771,200 into a fund that helps rural communities across the state attract business in the future. When companies select a site located in a Tier 2 county such as Lee, their JDIG agreements move some of the new tax revenue into the state's Industrial Development Fund – Utility Account. Local communities in more economically challenged areas of the state use grants from the Utility Account to build public infrastructure projects, which can improve a community's ability to attract companies to their regions.
"We welcome these new biomanufacturing jobs to Lee County," said N.C. Representative John Sauls. "Our region is a vital part of North Carolina's growing life science industry cluster, and we're excited to see the many opportunities that Abzena will bring to our community."
"Many economic development partners worked together to bring this investment to Lee County," said N.C. Senator Jim Burgin. "These community partners will continue to collaborate with Abzena to help the company succeed now and for many years to come."
Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of N.C. on this project were the North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, the Office of Senator Thom Tillis, Duke Energy, the City of Sanford, Lee County, and the Sanford Area Growth Alliance.
0 Comments
Latest on ncarol.com
- Vision Elite Royalty Announces Major Rebrand
- Providence Place Hosts Community Easter Event for Local Children in High Point
- Century Fasteners Corp. Exhibiting at 2026 MRO Americas Show – April 21-23, 2026 – Booth #2257
- Why Most "Artist Deals" Are Just Repackaged Services — And What Real Music Infrastructure Really Is
- Blue Sparrow Coffee named Best Matcha in Westword's Best of Denver 2026
- Ocean County College Introduces Pathways to Simplify the Student Journey and Strengthen Career Connections
- Kiko Nation Expands to Apple App Store, Achieving Full Mobile Deployment for Livestock Digital Registry Platform
- The Lawyers' Marketer Launches Claude AI Implementation Service for Law Firms
- Certified Trading Card Association and Collectors MD Launch Healthy Hobby Initiative
- Independent Artist Builds AI-Driven Soul Collective to Scale Music Creation
- L2 Aviation Earns FAA STC for Thales AVIATOR 200S for Boeing 777
- FinIQ Edu Launches High-Impact Workshop Vertical to Close the Workplace Benefits Gap—Drives 82% Surge in 401(k) Participation Intent
- HousingWire launches Mortgage Rankings, bringing a data-driven benchmark to originator performance
- J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
- Charlotte-based PR Founder + Expert Launches New Website Highlighting Brand Astrology™ Methodology
- Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
- IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
- AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
- Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)